RBC Capital analyst Kennen MacKay raised the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Baird Incrementally Positive on Aimmune Therapeutics (AIMT) ARTEMIS Topline ReadoutMarch 25, 2019 12:52 PM Pre-Open Stock Movers 03/25: (CRIS) (AVYA) (AIMT) Higher; (PTI) (REPH) (AKAM) Lower (more...)March 25, 2019 9:26 AM Form 8-K Aimmune Therapeutics, For: Mar 25March 25, 2019 8:17 AM Aimmune Therapeutics (AIMT) Says European Phase 3 Trial of its AR101 Meets Primary EndpointMarch 25, 2019 8:01 AM European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary EndpointMarch 25, 2019 8:00 AM